Obesity Drug Price War Fears Impact Health Care Stocks
In a shocking turn of events, health-care companies are feeling the heat as obesity-drug makers engage in a price...
Revolutionize Your Finance News Experience with MorningExpert!
🌟 Custom-Tailored News Just for You: Say goodbye to information overload. Our cutting-edge filtering technology curates your feed to perfection, delivering only the finance news that matches your interests and professional ambitions.
🔔 Flexible Updates, Your Way: How do you like your updates? Choose from instant app notifications, email digests, or captivating video summaries to stay informed on your own terms.
🎥 Engaging Video Summaries: Pressed for time? Let our expert anchors brief you with video summaries, giving you the essence of each news piece in minutes.
🚨 Personalized Alerts: Never miss out on what matters most. Set custom alarms for topics you’re passionate about, and be the first in the know.
📹 Create Your Own Video Content: Dive deeper into the topics that intrigue you with personalized videos. Generated on demand, these videos bring your chosen keywords or interests to life.
MorningExpert is more than a news app; it’s a dedicated companion for anyone passionate about finance. Whether you’re a seasoned professional, an avid enthusiast, or simply eager to stay updated with the finance world, our app ensures you’re always ahead of the curve.
With features designed to make staying informed effortless and enjoyable—such as custom alarms and on-demand video content—navigating the finance landscape has never been simpler or more tailored to your needs.
Transform the way you consume finance news. Download MorningExpert now and step into a world of precision-informed finance knowledge. Your next-level finance journey starts here!
acquisition adjusted earnings AI analysts apple artificial intelligence Bitcoin CEO China demand dividend Donald Trump Dow Jones Industrial Average earnings economy extreme event FactSet Federal Reserve fourth quarter growth guidance hamas inflation interest rates investment investors Israel Microsoft net income net profit Nvidia profit revenue revenue growth S&P 500 sales shareholders shares stock stock market stocks tesla third quarter Trump Wall Street
In a shocking turn of events, health-care companies are feeling the heat as obesity-drug makers engage in a price...
In a groundbreaking study, Novo Nordisk's obesity drug Liraglutide has shown promising results in reducing body-mass index for children...
Eli Lilly & Co.'s shares soared on Thursday after the drugmaker reported second-quarter earnings that surpassed expectations, driven by...
In the competitive world of weight-loss drugs, Eli Lilly and Novo Nordisk currently dominate the market with injectable GLP-1s...
Lead: Amgen's stock skyrockets as the company unveils promising results for its experimental obesity drug, MariTide, sparking optimism among...
Lead: Amgen's injectable obesity drug, MariTide, is gaining momentum towards market approval, causing a surge in the company's stock....
Lead: Eli Lilly, the pharmaceutical giant, is set to announce its quarterly results, with investors eagerly awaiting updates on...
Lead: Health-care companies are on the rise as Novo Nordisk's obesity drug, Amycretin, outperforms its popular Wegovy drug in...
Lead: Novo Nordisk's shares soar to a record high as the company unveils promising early data for a new...
Eli Lilly will reveal sales figures for its new obesity medicine, Zepbound, during its fourth-quarter earnings report on Tuesday....